Inspiring Seniors Towards Exercise Promotion - 2
iSTEP-2
2 other identifiers
interventional
150
1 country
1
Brief Summary
Older adults' low adherence to the national physical activity guidelines may stem from a failure to increase positive affective responses to exercise (e.g., enjoyment). Exercising with personalized, tempo-synchronous music playlists has shown promising effects on physical activity promotion in midlife-to-older adults during a cardiac rehab program. The purpose of this study is to determine how personalized, tempo-synchronous music playlists called rhythmic auditory stimulation (RAS) influence exercise behavior change and affective responses to exercise over 8 months among community-dwelling, sedentary older adults.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2026
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 14, 2026
CompletedStudy Start
First participant enrolled
May 26, 2026
CompletedFirst Posted
Study publicly available on registry
June 5, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 1, 2028
June 5, 2026
June 1, 2026
2.2 years
May 14, 2026
June 1, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Weekly volume of light, moderate, and vigorous physical activity as assessed by ActiGraph
Duration, intensity, and frequency of physical activity will be assessed using a waist-worn accelerometer.
7 consecutive days at Baseline (before the intervention) and during month 1, 2, 3, 4, 5, and 6 (during intervention) and month 8 (2 months post-intervention)
Physical activity behaviors as assessed by an Exercise Log
Daily duration and types of physical activity will be self-reported on an exercise log.
During month 1, 2, 3, 4, 5, 6, 7 (during the intervention) and month 8 (2 months post - intervention until 2-month post-intervention)
The single-item Feeling Scale (FS)
The single-item Feeling Scale (FS) will be used to measure affective responses to physical activity as assessed by Ecological Momentary Assessment (EMA). How are you feeling right now? with 11-point rating scale scores ranging from -5 to +5, with labels -5 = very bad, -3 = bad, -1 = somewhat bad, 0 = neutral, +1 = somewhat good, +3 = good, and +5 = very good.
For 3 days at Baseline (before the intervention), weekly during month 1, 2, 3, 4, 5, and 6 (during intervention), and for 3 days in month 8 (2 months post-intervention)
Secondary Outcomes (26)
Borg's Rating of Perceived Exertion (RPE) scale
For 3 days at Baseline (before the intervention), weekly during month 1, 2, 3, 4, 5, and 6 (during intervention), and for 3 days in month 8 (2 months post-intervention)
Cognitive Change Index (CCI-12)
At pre-test (before the intervention) and 6 weeks post-intervention
Behavioural Regulation in Exercise Questionnaire-3 (BREQ-3)
Baseline (pre-intervention), and during month 3 and 6 (during intervention) and month 8 (2 months post-intervention)
Physical Activity Enjoyment Scale (PACES)
Baseline (pre-intervention), and during month 3 and 6 (during intervention) and month 8 (2 months post-intervention)
Self-Efficacy for Exercise Scale (SEE)
Baseline (pre-intervention), and during month 3 and 6 (during intervention) and month 8 (2 months post-intervention)
- +21 more secondary outcomes
Study Arms (2)
Exercise intervention with RAS (EX+RAS)
EXPERIMENTALParticipants will be randomized to an exercise intervention with RAS (EX+RAS) over 6 months, offering the exercise prescription to foster independent adherence to the Physical Activity guidelines (PAG) through the gradual withdrawal of supervised training. This group will be provided with RAS playlists and trained to use them for their exercise sessions.
Exercise intervention without RAS (EX)
ACTIVE COMPARATORParticipants will be randomized to an exercise intervention (EX) over 6 months, offering the same exercise prescription as the experimental group, to foster independent adherence to the PAG through the gradual withdrawal of supervised training. This group will not be provided with any RAS playlists to accompany their exercise.
Interventions
Supervised exercise sessions will be led by an exercise specialist at an open-floor gym. All participants will be asked to attend a supervised group exercise session for moderate aerobic training (MAT) for 15-40 minutes/day and muscle-strengthening training (ST) for 15-20 minutes/day for 2 days/week for the first 3 months, while being encouraged to independently perform MAT on up to 3 more days/week. Then, the same training session will be offered for 1 day/week for an additional 3 months while encouraging participants to independently perform ST on 1 more day of the week and MAT up to 4 more days of the week. Participants will be instructed on set and track exercise goals, supplemented with a series of behavioral supports during the 6-month intervention and until a 2-month post-intervention follow-up.
Supervised exercise sessions will be led by an exercise specialist at an open-floor gym. All participants will be asked to attend a supervised group exercise session for moderate aerobic training (MAT) for 15-40 minutes/day and muscle-strengthening training (ST) for 15-20 minutes/day for 2 days/week for the first 3 months, while being encouraged to independently perform MAT on up to 3 more days/week. Then, the same training session will be offered for 1 day/week for an additional 3 months while encouraging participants to independently perform ST on 1 more day of the week and MAT up to 4 more days of the week. Participants will be instructed on set and track exercise goals, supplemented with a series of behavioral supports during the 6-month intervention and until a 2-month post-intervention follow-up.
Eligibility Criteria
You may qualify if:
- Adults over 65 years old.
- Ambulatory without pain or the use of assisted walking devices.
- Able to speak and read English.
- Healthy enough to exercise at moderate intensity with or without medical clearance by a primary care physician.
- Living in the community for the duration of the study (9-10 months).
- Having a reliable means of transportation.
- Having a safe place at home or at a residential area (at least 6 feet by 6 feet of open space) for unsupervised exercise training.
- Being low-active (\< 90 min/week of MAT and \< 2 days/week of ST for the last 3 months).
You may not qualify if:
- Concurrent diagnosis of neurological disorder (e.g., dementia, Parkinson's disease, multiple sclerosis, etc.), determined by self-report on the Physical Activity Readiness Questionnaire for Everyone (PAR-Q+).
- Known exercise contraindications (uncontrolled hypertension, joint problems, diabetes, metabolic conditions, etc.), determined by self-report on the PAR-Q+.
- Current or upcoming cancer treatment, determined by self-report on the PAR-Q+.
- Stroke or neural impairment in the past 6 months, as self-reported on the PAR-Q+.
- Hip/knee/spinal fracture or surgery in the past 6 months, determined by self-report on the ACSM Health Screening Questionnaire.
- Unable or unwilling to attend intervention classes, as determined by phone screening.
- Currently participating in any other exercise or fitness-related research study, determined by phone screening.
- Use of medications for cognitive impairment, as self-reported on the medication survey.
- Change in dosage of medications prescribed for anxiety or depression within the previous 6 months, determined by self-report on a medication form.
- Self-report regularly drinking \> 14 alcoholic beverages a week or current illicit drug use, determined by self-report to screening surveys.
- Cannot ambulate without a walker/cane, assessed in the American College of Sports Medicine (ACSM) Health Screening Questionnaire
- Having cognitive impairment, determined by the Montreal Cognitive Assessment (MoCA) BLIND \< 17.
- Meet the threshold for clinical depression, determined by the Center for Epidemiological Studies Depression Scale Revised (CESD-R).
- Uncorrected hearing or visual impairments, self-reported on the Health History Questionnaire.
- Unable to understand the study procedure.
- +1 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Emory Universitylead
- National Institute on Aging (NIA)collaborator
Study Sites (1)
Emory University
Atlanta, Georgia, 30329, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kyoung Shin Park, PhD
Emory University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
May 14, 2026
First Posted
June 5, 2026
Study Start
May 26, 2026
Primary Completion (Estimated)
August 1, 2028
Study Completion (Estimated)
August 1, 2028
Last Updated
June 5, 2026
Record last verified: 2026-06
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ANALYTIC CODE
- Time Frame
- Data will be shared beginning 9 months following the article publication and will be available for at least 10 years after the end of the funding period.
- Access Criteria
- Data will be shared with anyone who registers with the repository and agrees to its Terms of Use, which limit data use to scientific research and aggregate statistical reporting, prohibit attempts to re-identify study participants, and prohibit redistribution of downloaded data. Data will be shared for any scientific research or aggregate statistical reporting consistent with the Terms of Use. Data will be deposited in UNC Dataverse, which assigns a DOI as a persistent identifier and provides searchable study-level metadata for discovery. The dataset will be available for direct download through the repository interface upon registration and acceptance of the Terms of Use.
Researchers will share individual deidentified participant data that underlie the results reported from this trial (text, tables, figures, and appendices).